BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2171543)

  • 1. [Serum antibodies against hepatitis C: study of 4,100 blood donors from the northeast of France].
    Aymard JP; Janot C; Adjizian JC; Tamisier C; Humbert JC; Billuart M; Streiff F
    Rev Fr Transfus Hemobiol; 1990 Jul; 33(4):295-302. PubMed ID: 2171543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels.
    Lai ME; Mazzoleni AP; Farci P; Melis A; Porru A; Orgiana G; Arnone M; Balestrieri A
    J Med Virol; 1993 Dec; 41(4):282-8. PubMed ID: 7508972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of anti-HCV among voluntary blood donors in Taiwan.
    Tsai SJ; Chen CJ; Hsieh YS; Yang CS
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Feb; 24(1):61-70. PubMed ID: 1657546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of anti-HCV in Norwegian blood donors with anti-HBc or increased ALT levels.
    Hetland G; Skaug K; Larsen J; Maland A; Strømme JH; Størvold G
    Transfusion; 1990; 30(9):776-9. PubMed ID: 2173175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis C virus antibodies in Sydney blood donors.
    Archer GT; Buring ML; Clark B; Ismay SL; Kenrick KG; Purusothaman K; Kaldor JM; Bolton WV; Wylie BR
    Med J Aust; 1992 Aug; 157(4):225-7. PubMed ID: 1279363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antibody to hepatitis C virus in a blood donor population.
    Richards C; Holland P; Kuramoto K; Douville C; Randell R
    Transfusion; 1991 Feb; 31(2):109-13. PubMed ID: 1847559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore.
    Kuperan P; Choon AT; Ding SH; Lee G
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():127-9. PubMed ID: 7533946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of hepatitis C virus antibodies and serum alanine amino transferase in blood donors in Hong Kong Chinese.
    Lin CK; Chu R; Li KB; Leong S
    Vox Sang; 1992; 62(2):98-101. PubMed ID: 1325715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia.
    Abdelaal M; Rowbottom D; Zawawi T; Scott T; Gilpin C
    Transfusion; 1994 Feb; 34(2):135-7. PubMed ID: 8310483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of hepatitis C RNA and serum alanine aminotransferase in hepatitis B and C seronegative healthy blood donors.
    Ali N; Moiz B; Moatter T; Ahmed S; Adil SN; Khurshid M
    Indian J Pathol Microbiol; 2010; 53(3):480-5. PubMed ID: 20699507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels.
    Rossini A; Gazzola GB; Ravaggi A; Agostinelli E; Biasi L; Albertini A; Radaeli E; Cariani E
    Transfusion; 1995 Feb; 35(2):108-11. PubMed ID: 7529954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
    Baur P; Roelcke D
    Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients.
    Widell A; Sundström G; Hansson BG; Moestrup T; Nordenfelt E
    Vox Sang; 1991; 60(1):28-33. PubMed ID: 1647082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
    Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
    Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening of Danish blood donors for hepatitis C virus antibodies].
    Wantzin PS; Krogsgaard K; Dickmeiss E
    Ugeskr Laeger; 1990 Sep; 152(39):2846-8. PubMed ID: 2120833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-specific and specific anti-HCV results correlated to age, sex, transaminase, rhesus blood group and follow-up in blood donors.
    Caspari G; Gerlich WH; Beyer J; Schmitt H
    Arch Virol; 1997; 142(3):473-89. PubMed ID: 9349294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.